Loading clinical trials...
Loading clinical trials...
A Randomised, Double-Blind, Placebo-Controlled, Cardiovascular Magnetic Resonance (CMR) Study to Evaluate the Effect of Rosiglitazone on Carotid Atherosclerotic Plaques in Type 2 Diabetics With Vascular Disease or Hypertension
Conditions
Interventions
Rosiglitazone
Locations
2
United Kingdom
Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital
London, United Kingdom
St Mary's NHS Trust
London, United Kingdom
Start Date
October 1, 2002
Completion Date
May 1, 2005
Last Updated
August 1, 2005
NCT02417740
NCT07073820
NCT07480265
NCT06876233
NCT06909773
NCT06505109
Lead Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions